Synthetic Periwinkle: Emulating Nature For Drug Discovery

With its resplendent flowers, the Madagascar periwinkle plant (Catharanthus roseus) easily draws attention to itself, both in a natural setting and in ...

April 01, 2023 | Saturday | Analysis
Novel Approaches for Engineering AAV Vectors for Gene Therapy

AAVs make ideal gene therapy vectors due to their small size, genetic simplicity, and low immunogenicity. However, several limitations are hindering the wi...

April 01, 2023 | Saturday | News
Using CRISPR-edited iPSCs to Understand Alzheimer’s Disease

More recently, the CRISPR system has been used to edit human induced pluripotent stem cells (iPSCs), which are known to exhibit phenotypes closer to human ...

April 01, 2023 | Saturday | Analysis
COVID-19 Infection Shown to Significantly Increase Drug Clearance of Therapeutic Monoclonal Antibodies

Patients with inflammatory diseases being treated with therapeutic monoclonal antibodies (mAbs) such as Infliximab may experience a significant increase in...

March 30, 2023 | Thursday | News
Thermo Fisher Scientific and Arsenal Biosciences Collaborate to Support Clinical Manufacturing of Autologous T-Cell Therapies

ArsenalBio recently advanced its lead product candidate into clinical manufacturing of its autologous integrated circuit T cell (ICT) therapy for...

March 29, 2023 | Wednesday | News
Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate adv...

March 28, 2023 | Tuesday | News
Sandoz announces agreement to acquire leading antifungal agent Mycamine® from Astellas

Sandoz plans to acquire worldwide product rights for Mycamine® (micafungin sodium) from Astellas Acquiring leading global echinocandin, one of three...

January 24, 2023 | Tuesday | News
Genomic Vision strengthens its management by welcoming Frédéric Hammel as Chief Operating Officer

Frédéric, a biologist by training (ENS, MBA from the College of Engineers), is a recognized leader, with more than 25 years of experience in ...

January 24, 2023 | Tuesday | News
PCR-based PoC Platforms for Infectious Disease Testing Growth Opportunities

The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respiratory tract pathogens are notewor...

January 24, 2023 | Tuesday | News
CytoSMART Technologies Joins the Axion BioSystems Brand

According to Axion CEO Kevin Gould, “Bringing all of our instruments under the Axion BioSystems umbrella helps ensure all of our customers receive th...

January 24, 2023 | Tuesday | News
AskBio Announces Strategic Collaboration with ReCode Therapeutics to Explore Single Vector Gene Editing Platform

Under this agreement, the companies will work together to potentially discover precision genetic medicines through the development of a novel platform for ...

January 12, 2023 | Thursday | News
Integral Molecular Reveals Mechanism Underlying Exquisite Specificity of Claudin 6 Therapeutic Antibody Being Developed for Solid Tumors

Integral Molecular, the industry leader in antibody discovery for membrane proteins, has published the targeting mechanism enabling best-in-class specifici...

January 06, 2023 | Friday | News
Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies

EVOQ’s NanoDisc technology is designed to enable lymph-targeted delivery of disease-specific antigens and has the potential to change the paradigm fo...

January 05, 2023 | Thursday | News
CANbridge Consolidates Gene Therapy Portfolio

Secures Exclusive Global Rights to Potentially Best-in-Class Spinal Muscular Atrophy Gene Therapy from UMass Chan Medical School Completes Technology Tr...

January 04, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close